Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute‐designated cancer center

Abstract Introduction Tobacco cessation is a critical but challenging intervention for cancer patients. Our National Cancer Institute‐designated Comprehensive Cancer Center instituted a tobacco cessation program in 2019. This manuscript reports on the first 2 years of our experience. Methods Patient...

Full description

Bibliographic Details
Main Authors: Sarah A. Westergaard, Manali Rupji, Lauren E. Franklin, Madhusmita Behera, Suresh S. Ramalingam, Kristin A. Higgins
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5423
_version_ 1797854217646374912
author Sarah A. Westergaard
Manali Rupji
Lauren E. Franklin
Madhusmita Behera
Suresh S. Ramalingam
Kristin A. Higgins
author_facet Sarah A. Westergaard
Manali Rupji
Lauren E. Franklin
Madhusmita Behera
Suresh S. Ramalingam
Kristin A. Higgins
author_sort Sarah A. Westergaard
collection DOAJ
description Abstract Introduction Tobacco cessation is a critical but challenging intervention for cancer patients. Our National Cancer Institute‐designated Comprehensive Cancer Center instituted a tobacco cessation program in 2019. This manuscript reports on the first 2 years of our experience. Methods Patients were referred to the program by their care team, and a certified tobacco treatment specialist contacted patients remotely and provided behavioral therapy and coordinated pharmacotherapy. We retrospectively captured data from patients with a cancer diagnosis referred to the tobacco cessation program. Univariate and multivariable logistic regression analyses with the backward elimination approach were performed to determine factors associated with patient acceptance of referral to the tobacco cessation program. Tobacco cessation rates after referral to the program were also captured. Results Between July 2019 and August 2021, 194 patients were referred to the tobacco cessation program. Of the 194 patients referred, 93 agreed to enroll in the tobacco cessation program (47.9%), of which 84 requested pharmacotherapy (90.3%). Twenty‐four were able to cease tobacco use (25.8%). Only 7 patients out of the 101 patients (6.9%) who declined cessation services were successful (p < 0.001). On univariate logistic regression, race (p = 0.027) and marital status (p = 0.020) were associated with referral acceptance. On multivariable analysis, single patients (odds ratio [OR] = 0.33) and Caucasian patients (OR = 0.43) were less likely to accept a referral. Conclusions Access to tobacco cessation services is a critical component of comprehensive cancer care. Our experience highlights the need to understand patient‐specific factors associated with engagement with a tobacco cessation program during cancer treatment. The use of pharmacotherapy is also a critical component of successful tobacco cessation.
first_indexed 2024-04-09T20:02:58Z
format Article
id doaj.art-a2b1f08bf59b49508a2109caf908f457
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-09T20:02:58Z
publishDate 2023-03-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-a2b1f08bf59b49508a2109caf908f4572023-04-02T20:55:00ZengWileyCancer Medicine2045-76342023-03-011267339734710.1002/cam4.5423Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute‐designated cancer centerSarah A. Westergaard0Manali Rupji1Lauren E. Franklin2Madhusmita Behera3Suresh S. Ramalingam4Kristin A. Higgins5Winship Cancer Institute of Emory University Atlanta Georgia USAWinship Cancer Institute of Emory University Atlanta Georgia USAWinship Cancer Institute of Emory University Atlanta Georgia USAWinship Cancer Institute of Emory University Atlanta Georgia USAWinship Cancer Institute of Emory University Atlanta Georgia USAWinship Cancer Institute of Emory University Atlanta Georgia USAAbstract Introduction Tobacco cessation is a critical but challenging intervention for cancer patients. Our National Cancer Institute‐designated Comprehensive Cancer Center instituted a tobacco cessation program in 2019. This manuscript reports on the first 2 years of our experience. Methods Patients were referred to the program by their care team, and a certified tobacco treatment specialist contacted patients remotely and provided behavioral therapy and coordinated pharmacotherapy. We retrospectively captured data from patients with a cancer diagnosis referred to the tobacco cessation program. Univariate and multivariable logistic regression analyses with the backward elimination approach were performed to determine factors associated with patient acceptance of referral to the tobacco cessation program. Tobacco cessation rates after referral to the program were also captured. Results Between July 2019 and August 2021, 194 patients were referred to the tobacco cessation program. Of the 194 patients referred, 93 agreed to enroll in the tobacco cessation program (47.9%), of which 84 requested pharmacotherapy (90.3%). Twenty‐four were able to cease tobacco use (25.8%). Only 7 patients out of the 101 patients (6.9%) who declined cessation services were successful (p < 0.001). On univariate logistic regression, race (p = 0.027) and marital status (p = 0.020) were associated with referral acceptance. On multivariable analysis, single patients (odds ratio [OR] = 0.33) and Caucasian patients (OR = 0.43) were less likely to accept a referral. Conclusions Access to tobacco cessation services is a critical component of comprehensive cancer care. Our experience highlights the need to understand patient‐specific factors associated with engagement with a tobacco cessation program during cancer treatment. The use of pharmacotherapy is also a critical component of successful tobacco cessation.https://doi.org/10.1002/cam4.5423C3IcancerNCItobacco cessation
spellingShingle Sarah A. Westergaard
Manali Rupji
Lauren E. Franklin
Madhusmita Behera
Suresh S. Ramalingam
Kristin A. Higgins
Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute‐designated cancer center
Cancer Medicine
C3I
cancer
NCI
tobacco cessation
title Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute‐designated cancer center
title_full Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute‐designated cancer center
title_fullStr Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute‐designated cancer center
title_full_unstemmed Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute‐designated cancer center
title_short Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute‐designated cancer center
title_sort engagement and outcomes of cancer patients referred to a tobacco cessation program at a national cancer institute designated cancer center
topic C3I
cancer
NCI
tobacco cessation
url https://doi.org/10.1002/cam4.5423
work_keys_str_mv AT sarahawestergaard engagementandoutcomesofcancerpatientsreferredtoatobaccocessationprogramatanationalcancerinstitutedesignatedcancercenter
AT manalirupji engagementandoutcomesofcancerpatientsreferredtoatobaccocessationprogramatanationalcancerinstitutedesignatedcancercenter
AT laurenefranklin engagementandoutcomesofcancerpatientsreferredtoatobaccocessationprogramatanationalcancerinstitutedesignatedcancercenter
AT madhusmitabehera engagementandoutcomesofcancerpatientsreferredtoatobaccocessationprogramatanationalcancerinstitutedesignatedcancercenter
AT sureshsramalingam engagementandoutcomesofcancerpatientsreferredtoatobaccocessationprogramatanationalcancerinstitutedesignatedcancercenter
AT kristinahiggins engagementandoutcomesofcancerpatientsreferredtoatobaccocessationprogramatanationalcancerinstitutedesignatedcancercenter